Company / Operating Income per Share
Astria Therapeutics, Inc. Operating Income per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.99
FY2024
5-year range
-$21.85 / -$1.99
FY2020-FY2024
Trend
+27.9%
vs FY2023
Sector context
#117 of 201
Health Care
What the data says
At $-1.99, Astria Therapeutics, Inc.'s operating income per share ranks #117 of 201 in the Health Care sector. Operating Income per Share has increased for 3 consecutive years, from $-21.85 in FY2021 to $-1.99 in FY2024.
Based on SEC 10-K filings.
-1.99 in FY2024.
Improved from $-3.66 to $-1.99 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#117 of 201 in Health CareTop 58% of 201This company -$1.99 Sector average -$28.56
▼
+93.0% above sector average
Key checks
Key Insights
- Astria Therapeutics, Inc.'s operating income per share has grown for 3 consecutive years.
- In FY2024, operating income per share increased 27.9% year-over-year.
- Ranks #117 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$1.99 | +27.9% |
| FY2023 | -$2.76 | +24.7% |
| FY2022 | -$3.66 | +83.2% |
| FY2021 | -$21.85 | -78.5% |
| FY2020 | -$12.24 | -337.7% |
| FY2019 | -$2.80 | +46.4% |
| FY2018 | -$5.22 | +58.3% |
| FY2017 | -$12.50 | -470.4% |
| FY2016 | -$2.19 | +44.3% |
| FY2015 | -$3.94 | +92.3% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026